Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.24.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used